Related Experiment Video
Updated: Sep 12, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Impact of Intensive Blood Pressure Control Versus Standard Control on Cardiovascular Outcomes: A Systematic Review
Ufn Rizwanullah1, Allenki Vineesh2, Fardin Akbar Hyderi3
1Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Insights
Intensive blood pressure control significantly reduces major adverse cardiovascular events (MACE) and cardiovascular mortality. However, it increases risks of adverse events like hypotension, requiring individualized treatment decisions for hypertension management.
Area of Science:
- Cardiology
- Clinical Medicine
- Public Health
Background:
- Hypertension is a leading non-inherited risk factor for cardiovascular disease.
- Optimal blood pressure targets for cardiovascular disease prevention remain debated.
- Major adverse cardiovascular events (MACE) are critical outcomes in hypertension management.
Purpose of the Study:
- To compare intensive blood pressure control versus standard control for cardiovascular outcomes.
- To specifically analyze the impact on major adverse cardiovascular events (MACE).
- To evaluate the balance between benefits and risks of intensive blood pressure management.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Searched PubMed, Embase, and Cochrane Library up to March 2025.
- Analyzed MACE (all-cause mortality, cardiovascular mortality, MI, stroke, heart failure) and adverse events using random effects models.
Main Results:
- Intensive blood pressure control significantly reduced MACE (RR: 0.80, 95% CI: 0.73-0.88).
- Significant reductions observed in cardiovascular mortality (RR: 0.78), stroke (RR: 0.78), and heart failure (RR: 0.73).
- Increased risks of hypotension, syncope, electrolyte imbalance, and acute kidney injury were associated with intensive control.
Conclusions:
- Lower blood pressure targets offer significant cardiovascular benefits, reducing MACE, cardiovascular mortality, stroke, and heart failure.
- These benefits must be balanced against an increased risk of adverse events.
- Individualized treatment decisions are crucial, considering patient factors and preferences.
Abstract:
Hypertension is one of the most frequent non-inherited risks to health that contributes to cardiovascular disease. Whereas the effects of reducing blood pressure are clear-cut, it is debatable what the optimal blood pressure level should be maintained. The objective of this systematic review and meta-analysis was to compare intensive blood pressure control with standard blood pressure control regarding cardiovascular outcomes, specifically focusing on major adverse cardiovascular events (MACE). We searched electronic databases comprehensively (PubMed, Embase, and Cochrane Library) from inception up to March 2025 to find randomized controlled trials comparing intensive control of systolic blood pressure with standard control. The primary outcome was MACE, a composite measure including all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, heart failure, and adverse events. Meta-analysis was performed using random effects to measure risk ratios (RRs) and 95% confidence intervals (CIs). Our analysis incorporated 37,249 subjects from 12 randomized controlled trials. Intensive blood pressure control significantly decreased the odds of MACE (RR: 0.80, 95% CI: 0.73-0.88) compared to standard management. Notable reductions were also observed in cardiovascular mortality (RR: 0.78, 95% CI: 0.67-0.90), stroke (RR: 0.78, 95% CI: 0.68-0.90), and heart failure (RR: 0.73, 95% CI: 0.61-0.88). However, intensive management was associated with higher risks of hypotension, syncope, electrolyte imbalance, and acute kidney injury. Overall, our results indicate that achieving lower blood pressure targets yields significant cardiovascular benefits, particularly in reducing MACE, cardiovascular mortality, stroke, and heart failure. However, these advantages must be weighed against the increased risk of adverse events. Treatment decisions should be individualized based on patient characteristics, risk factors, and preferences. Additionally, moderate heterogeneity was noted across studies, and the risk of bias was assessed, revealing good methodological quality overall.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies

